Inhibition of enzymatic proteolysis; effect of carbonyl group reagents on the activity of kidney cathepsins.

O. Schales,B. Hill

1949-07-01

Abstract:

What problem does this paper attempt to address?

Extracellular Vesicle-Associated Neutrophil Elastase Activates Hepatic Stellate Cells and Promotes Liver Fibrogenesis via ERK1/2 Pathway

Regina Oshins,Zachary Greenberg,Yun-Ling Tai,Derrick Zhao,Xuan Wang,Borna Mehrad,Mei He,Ishan Patel,Laith Khartabil,Huiping Zhou,Mark Brantly,Nazli Khodayari

DOI: https://doi.org/10.1101/2024.08.20.608832

2024-08-21

Abstract:Liver fibrosis associated with increased mortality is caused by activation of hepatic stellate cells and excessive production and accumulation of extracellular matrix in response to fibrotic insults. It has been shown that in addition to liver inflammation, systemic inflammation also contributes to liver fibrogenesis. A deeper understanding of mechanisms that control liver fibrotic response to intra- and extra-hepatic inflammation is essential to develop novel clinical strategies against this disease. Extracellular vesicles (EV) have been recognized as immune mediators that facilitate activation of hepatic stellate cells. In inflammatory diseases, activated neutrophils release neutrophil elastase (NE) bound to EV, which has been identified as a significant contributor to inflammation by promoting immune cell activation. Here, we aimed to explore the role of inflammation derived plasma EV-associated NE in liver fibrogenesis and its potential mechanisms. We show EV-associated NE induces activation, proliferation and migration of hepatic stellate cells by promoting activation of the ERK1/2 signaling pathway. This effect did not occur through EV without surface NE, and Sivelestat, a NE inhibitor, inhibited activation of the ERK1/2 signaling pathway mediated by EV-associated NE. Moreover, we found plasma EV-associated NE increases deposition of collagen1 and α-smooth muscle actin in the liver of a mouse model of liver fibrosis (Mdr2-/-). Notably, this effect does not occur in control mice without preexisting liver disease. These data suggest that EV-associated NE is a pro-fibrogenic factor for hepatic stellate cell activation via the ERK1/2 signaling pathway in pre-existing liver injuries. Inhibition of the plasma EV-associated NE in inflammatory conditions may be a therapeutic target for liver fibrosis in patients with inflammatory diseases.

Biology
Extracellular vesicles-derived ferritin from lipid-induced hepatocytes regulates activation of hepatic stellate cells

Mengxue Sun,Min Tang,Yiting Qian,Guannan Zong,Gaowang Zhu,Yan Jiang,Yingjie Mu,Minjun Zhou,Qin Ding,Hao Wang,Fengshang Zhu,Changqing Yang

DOI: https://doi.org/10.1016/j.heliyon.2024.e33741

IF: 3.776

2024-06-27

Heliyon

Abstract:Introduction: and objectives: Extracellular vesicles (EVs) have emerged as key players in intercellular communication within the context of non-alcoholic fatty liver disease (NAFLD). This study aims to explore the intricate crosstalk between hepatocytes and hepatic stellate cells (HSCs) mediated by EVs in NAFLD. Materials and methods: EVs ferritin was detected in hepatocytes stimulated with free fatty acids (FFA) as well as in NAFLD mice. Deferoxamine (DFO) was employed to reduce ferritin levels, while GW4869 was utilized to inhibit EVs. The impact of EVs ferritin on the HSCs activation was evaluated both in vitro and in vivo. Additionally, serum EVs ferritin levels were compared between NAFLD patients and controls. Results: FFA treatment induces the formation and secretion of EVs and facilitates the release of ferritin from hepatocytes via EVs. Subsequently, EVs ferritin is hijacked by HSCs, prompting accelerated HSCs activation. Silencing ferritin with DFO and inhibiting EVs formation and secretion with GW4869 can reverse the effects of FFA treatment and disrupt the communication between hepatocytes and HSCs. Accumulation of ferritin leads to excessive reactive oxygen species (ROS) production, promoting HSCs fibrogenesis. Conversely, depleting EVs ferritin cargo restores liver function, concurrently mitigating NAFLD-associated fibrosis. Notably, NAFLD patients exhibit significantly elevated levels of serum EVs ferritin. Conclusions: This study unveils a previously underestimated role of ferritin in HSCs upon its release from hepatocytes, emphasizing DFO as a promising compound to impede NAFLD advancement.
The differential radiated power of a sinusoidal filament of electric current

J. Mautz,E. Arvas

DOI: https://doi.org/10.1109/APS.1997.631828

1997-07-13

Abstract:The authors consider a sinusoidal filament of current I(z)=u/sub z/I/sub m/ sin(k(H-|z|)), -H/spl les/z/spl les/H along the z-axis. The time dependence e/sup jwt/ is implicit, u/sub z/ is the unit vector in the z-direction, I/sub m/ is a complex constant, and k is the wavenumber in free space. From their analysis the differential radiated power appears to be identical to the differential input power and there seems to be no z-directed time-average power flow along the filament. The differential radiated power is the time-average power radiated per unit length along the filament. The differential input power is the time-average input power per unit length along the filament. The differential input power is negative for some values of z. The sections of the filament at these values of z absorb power radiated by other sections of the filament.
Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1

Fangjie Jiang,Qi Chen,Wei Wang,Yan Ling,Yan Yan,Pu Xia

DOI: https://doi.org/10.1016/j.jhep.2019.09.014

Abstract:Background & aims: Clinical evidence has indicated a close link between non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD). However, the underlying mechanism remains to be elucidated. This study aimed to explore a potential role of hepatocyte-derived extracellular vesicles (EVs) in endothelial inflammation and atherogenesis in the context of NAFLD. Methods: EVs were isolated, quantified and characterized from steatotic hepatocytes. An endothelial cell-specific PCR array was used to screen the functional properties of EVs. Profiling of global microRNA expression was conducted in EVs. The expression level and biological function of microRNA-1 (miR-1) was determined by quantitative PCR, immunoblot and reporter gene assays, respectively. The in vivo effect of miR-1 on atherogenesis was investigated in apolipoprotein E (ApoE)-deficient mice administered with a miR-1-specific inhibitor, antagomiR-1. Results: Steatotic hepatocytes released more EVs, which had significantly altered miRNA expression profiles compared to the EVs released by control hepatocytes. Endothelial cells co-cultured with steatotic hepatocytes, or treated with their EVs or miR-1, expressed significantly more proinflammatory molecules, as well as exhibiting increased NF-κB activity and reduced Kruppel-like factor 4 (KLF4) expression. EV-induced endothelial inflammation was prevented by either downregulation or inhibition of miR-1. While miR-1 treatment suppressed KLF4 expression and reporter gene activity, overexpression of KLF4 dramatically abolished the miR-1-induced endothelial inflammation. Moreover, not only did the miR-1 inhibitor reduce endothelial inflammation in vitro, but it also attenuated atherogenesis in ApoE-deficient mice. Conclusion: Steatotic hepatocyte-derived EVs promote endothelial inflammation and facilitate atherogenesis by miR-1 delivery, KLF4 suppression and NF-κB activation. The findings illustrate an important role of hepatocyte-derived EVs in distant communications between the liver and vasculature, suggesting a new mechanism underlying the link between NAFLD and CVD. Lay summary: Non-alcoholic fatty liver disease (NAFLD), a condition highly prevalent in obese and/or diabetic patients, is emerging as an independent risk factor of cardiovascular disease. Herein, we demonstrated that extracellular vesicles, released by hepatocytes under NAFLD conditions, cause vascular endothelial inflammation and promote atherosclerosis. Within these toxic vesicles, we identified a small molecular cargo that acted as a potent inducer of endothelial inflammation. By inhibiting this cargo's function, a specific gene-based inhibitor profoundly attenuated atherogenesis in mice, uncovering a novel mechanism which may be used to prevent or treat cardiovascular disease in patients with NAFLD.
Eggshell Membrane Ameliorates Hepatic Fibrogenesis in Human C3A Cells and Rats Through Changes in PPARγ-Endothelin 1 Signaling.

Huijuan Jia,Wanping Aw,Kenji Saito,Manaka Hanate,Yukio Hasebe,Hisanori Kato

DOI: https://doi.org/10.1038/srep07473

IF: 4.6

2014-01-01

Scientific Reports

Abstract:Our previous nutrigenomic findings indicate that eggshell membrane (ESM) may prevent liver fibrosis. Here we investigated the effects and mechanisms underlying ESM intervention against liver injury by using DNA microarray analysis and comparative proteomics. In vitro hydrolyzed ESM attenuated the TGFβ1-induced procollagen production of human hepatocyte C3A cells and inhibited the expression of Endothelin 1 ( EDN1 ) and its two receptors and extracellular matrix components. In vivo male Wistar rats were allocated into a normal control group, a CCl 4 group (hypodermic injection of 50% CCl 4 2×/wk) and an ESM group (20 g ESM/kg diet with CCl 4 injection) for 7 wks. Dietary ESM ameliorated the elevated activity of ALT/AST, oxidative stress and collagen accumulation in liver, accompanied by the down-regulated expression of Edn1 signaling and notable profibrogenic genes and growth factors as well as peroxisome proliferator-activated receptor gamma (PPARγ). Concomitantly, the decreased expressions of Galectin-1 and Desmin protein in the ESM group indicated the deactivation of hepatic stellate cells (HSCs). Through a multifaceted integrated omics approach, we have demonstrated that ESM can exert an antifibrotic effect by suppressing oxidative stress and promoting collagen degradation by inhibiting HSCs' transformation, potentially via a novel modulation of the PPARγ-Endothelin 1 interaction signaling pathway.
Characterization of highly porous polymeric materials with pore diameters larger than 100 nm by mercury porosimetry and X-ray scattering methods.

C. C. Egger,C. du Fresne,V. Raman,V. Schädler,T. Frechen,S. Roth,P. Müller‐Buschbaum

DOI: https://doi.org/10.1021/la800197p

IF: 3.9

2008-04-29

Langmuir

Abstract:Highly porous polymeric materials with pore sizes ranging from 100 nm to 1 microm are a very challenging class of materials not only to prepare synthetically (due to the high capillary pressures generated upon solvent removal) but also to characterize structurally. Through the examples of three different types of porous compounds synthesized in our laboratory (i) high-density melamine-based "MF-hd" with monomodal pore diameters around 500-900 nm, (ii) low-density melamine-based "MF-ld" with bimodal pore size distribution and average diameters around 2.3 microm and 350 nm, (iii) highly porous polyurethane "PU" with monomodal pore sizes around 150 nm, we confirm the limitations of mercury porosimetry as a means to investigate the architecture of materials with very high porosity (>80 vol %) and low compressive strength. Instead, a combination of high-resolution scanning electron microscopy and small-angle and ultrasmall-angle X-ray scattering (SAXS and USAXS, respectively) studies of these three types of materials helps in determining both the network and the pore structures. This work elucidates the need and applicability of the SAXS/USAXS techniques in characterizing such porous materials. For instance, the polyurethane specimens can only be quantitatively characterized by scattering techniques, the results of which are corroborated by high-resolution scanning electron microscopy observations.
Inspiratory flow rates during hard work when breathing through different respirator inhalation and exhalation resistances.

K. Coyne,D. Caretti,W. Scott,A. Johnson,F. Koh

DOI: https://doi.org/10.3320/1.2758453

Journal of Occupational and Environmental Hygiene

Abstract:There has been a long-standing debate regarding the adequacy of airflow rates used in respirator certification testing and whether these test flow rates underestimate actual values. This study investigated breath by breath inspiratory peak flow rate, minute ventilation, and instantaneous flow rates of eight young, healthy volunteers walking on a treadmill at 80-85% of maximal aerobic capacity until exhaustion while wearing an air-purifying respirator with one of eight combinations of inhalation and exhalation resistance. An analysis of variance was performed to identify differences among the eight conditions. Scheffe's post hoc analysis indicated which means differed. The group of conditions with the highest average value for each parameter was identified and considered to represent a worst-case scenario. Data was reported for these conditions. A Gaussian distribution was fit to the data and the 99.9% probability levels determined. The 99.9% probability level for the peak and instantaneous flow rates were 374 L/min and 336 L/min, respectively. The minute ventilation distribution was not Gaussian. Less than 1% of the recorded minute ventilations exceeded 135 L/min. Instantaneous flow rates exceeded the National Institute for Occupational Safety and Health's respirator test standards of 64, 85, and 100 L/min constant flow 91%, 87%, and 82% of the time, respectively. The recorded minute ventilations exceeded the 40 L/min minute ventilation test standard (for tests with a sinusoidal flow pattern) 100% of the time. This study showed that young, healthy respirator wearers generated peak flow rates, minute ventilations, and instantaneous flow rates that consistently exceeded current test standards. Their flow rates should be higher than those of a respirator wearer performing occupational work and could be considered upper limits. Testing respirators and respirator cartridges using a sinusoidal breathing pattern with a minute ventilation of 135 L/min (peak flow rate approximately 424 L/min) would encompass 99% of the recorded minute ventilations and 99.9% of the predicted peak and instantaneous flow rates from this study and would more accurately reflect human respiration during strenuous exercise.
Heparan Sulfate Proteoglycan-Mediated Internalization of Extracellular Vesicles Ameliorates Liver Fibrosis by Targeting Hepatic Stellate Cells

Rongrong Li,Chen Wang,Manqian Zhou,Yue Liu,Shang Chen,Zihan Chai,Haoyan Huang,Kaiyue Zhang,Zhibo Han,Guoqiang Hua,Nadia Benkirane-Jessel,Zhong-Chao Han,Zongjin Li

DOI: https://doi.org/10.1016/j.vesic.2022.100018

2022-01-01

Extracellular Vesicle

Abstract:Accumulating evidence shows that stem cell-derived extracellular vesicles (EVs) have shown great promise for tissue regeneration and are considered an alternative to cell-based therapy. However, the mechanisms by which EVs induce tissue repair have not been well demonstrated. Previous work indicates that activation of hepatic stellate cells (HSCs) may contribute to the progression of liver fibrosis. Here, we investigate the therapeutic potential of EVs derived from human placental mesenchymal stem cells (hP-MSCs) for the treatment of carbon tetrachloride (CCl4)-induced liver injury. Our data revealed that EVs derived from hP-MSCs effectively ameliorate liver injury by attenuating inflammation and fibrosis. Further data revealed that heparan sulfate proteoglycans (HSPGs) on the surface of HSCs mediate the internalization of EVs. Furthermore, EVs could inhibit the epithelial–mesenchymal transition (EMT) process in HSCs through the downregulated TGF-β/Smad pathway, which was mediated by miR-744-5p in EVs. Meanwhile, glycosaminoglycans on the surface of EVs play a crucial anti-inflammatory role. In conclusion, our results provide evidence that hP-MSC-derived EVs promote the recovery of liver injury by targeting HSPGs on HSCs and inhibiting liver inflammation through glycosaminoglycans from EVs. These findings may provide a novel theoretical basis for the treatment of liver fibrosis based on EVs.
Contribution of Hepatic Steatosis-Intensified Extracellular Vesicle Release to Aggravated Inflammatory Endothelial Injury in Liver-Specific Asah1 Gene Knockout Mice

Xinxu Yuan,Owais M Bhat,Yao Zou,Yang Zhang,Pin-Lan Li

DOI: https://doi.org/10.1016/j.ajpath.2022.12.007

Abstract:To study the mechanism by which nonalcoholic fatty liver disease (NAFLD) contributes to vascular endothelial Nod-like receptor pyrin domain 3 (NLRP3) inflammasome activation and neointima hyperplasia, NAFLD was established in high-fat diet (HFD)-treated Asah1fl/fl/Albcre (liver-specific deletion of the acid ceramidase gene Asah1) mice. Compared with Asah1 flox [Asah1fl/fl/wild type (WT)] and wild-type (WT/WT) mice, Asah1fl/fl/Albcre mice exhibited significantly enhanced ceramide levels and lipid deposition on HFD in the liver. Moreover, Asah1fl/fl/Albcre mice showed enhanced expression of extracellular vesicle (EV) markers, CD63 and annexin II, but attenuated lysosome-multivesicular body fusion. All these changes were accompanied by significantly increased EV counts in the plasma. In a mouse model of neointima hyperplasia, liver-specific deletion of the Asah1 gene enhanced HFD-induced neointima proliferation, which was associated with increased endothelial NLRP3 inflammasome formation and activation and more severe endothelial damage. The EVs isolated from plasma of Asah1fl/fl/Albcre mice on HFD were found to markedly enhance NLRP3 inflammasome formation and activation in primary cultures of WT/WT endothelial cells compared with those isolated from WT/WT mice or normal diet-treated Asah1fl/fl/Albcre mice. These results suggest that the acid ceramidase/ceramide signaling pathway controls EV release from the liver, and its deficiency aggravates NAFLD and intensifies hepatic EV release into circulation, which promotes endothelial NLRP3 inflammasome activation and consequent neointima hyperplasia in the mouse carotid arteries.
Threat Description for the PP by Using the Concept of the Assets Protected by TOE

Tai-hoon Kim,Byung-Gyu No,Dong Chun Lee

DOI: https://doi.org/10.1007/3-540-44864-0_63

2003-06-02

Abstract:
Wharton's Jelly mesenchymal stem cell-derived extracellular vesicles induce liver fibrosis-resolving phenotype in alternatively activated macrophages

Shukoofeh Torabi,Morteza Zarrabi,Faezeh Shekari,Hedie Poorkazem,Majid Lotfinia,Stefan Bencina,Roberto Gramignoli,Moustapha Hassan,Mustapha Najimi,Massoud Vosough

DOI: https://doi.org/10.1111/jcmm.18507

Abstract:The potential of extracellular vesicles (EVs) isolated from mesenchymal stromal cells in guiding macrophages toward anti-inflammatory immunophenotypes, has been reported in several studies. In our study, we provided experimental evidence of a distinctive effect played by Wharton Jelly mesenchymal stromal cell-derived EVs (WJ-EVs) on human macrophages. We particularly analyzed their anti-inflammatory effects on macrophages by evaluating their interactions with stellate cells, and their protective role in liver fibrosis. A three-step gradient method was used to isolate monocytes from umbilical cord blood (UCB). Two subpopulations of WJ-EVs were isolated by high-speed (20,000 g) and differential ultracentrifugation (110,000 g). Further to their characterization, they were designated as EV20K and EV110K and incubated at different concentrations with UCB-derived monocytes for 7 days. Their anti-fibrotic effect was assessed by studying the differentiation and functional levels of generated macrophages and their potential to modulate the survival and activity of LX2 stellate cells. The EV20K triggers the polarization of UCB-derived monocytes towards a peculiar M2-like functional phenotype more effectively than the M-CSF positive control. The EV20K treated macrophages were characterized by a higher expression of scavenger receptors, increased phagocytic capacity and production level of interleukin-10 and transforming growth factor-β. Conditioned medium from those polarized macrophages attenuated the proliferation, contractility and activation of LX2 stellate cells. Our data show that EV20K derived from WJ-MSCs induces activated macrophages to suppress immune responses and potentially play a protective role in the pathogenesis of liver fibrosis by directly inhibiting HSC's activation.
Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets

Liu Yang,Yawen Hao,Joost Boeckmans,Robim M Rodrigues,Yong He

DOI: https://doi.org/10.1016/j.pharmthera.2023.108353

Abstract:Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease worldwide. Despite extensive research and multiple clinical trials, there are still no FDA-approved therapies to treat the most severe forms of NAFLD. This is largely due to its complicated etiology and pathogenesis, which involves visceral obesity, insulin resistance, gut dysbiosis, etc. Although inflammation is generally believed to be one of the critical factors that drive the progression of simple steatosis to nonalcoholic steatohepatitis (NASH), the exact type of inflammation and how it contributes to NASH pathogenesis remain largely unknown. Liver inflammation is accompanied by the elevation of inflammatory mediators, including cytokines and chemokines and consequently intrahepatic infiltration of multiple types of immune cells. Recent studies revealed that extracellular vesicles (EVs) derived from inflammatory cells and hepatocytes play an important role in controlling liver inflammation during NASH. In this review, we highlight the roles of innate and adaptive immune cells and their microRNA-enriched EVs during NAFLD development and discuss potential drugs that target inflammatory pathways for the treatment of NAFLD.
Extracellular vesicles originating from steatotic hepatocytes promote hepatic stellate cell senescence via AKT/mTOR signaling

Zongmei Wu,Mengmeng Xia,Junyu Wang,Magnolia Martinez Aguilar,Manon Buist‐Homan,Han Moshage

DOI: https://doi.org/10.1002/cbf.4077

2024-06-18

Cell Biochemistry and Function

Abstract:The prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) is increasing rapidly due to the obesity epidemic. In the inflammatory stages of MASLD (MASH), activation of hepatic stellate cells (HSCs) leads to initiation and progression of liver fibrosis. Extracellular vesicles (EVs) are released from all cell types and play an important role in intercellular communication. However, the role of EVs released from hepatocytes in the context of MASLD is largely unknown. Therefore, the present study aimed to investigate the role of EVs derived from both normal and steatotic (free fatty acid‐treated) hepatocytes on the phenotype of HSCs via the senescence pathway. Primary rat hepatocytes were treated with free fatty acids (FFAs: oleic acid and palmitic acid). EVs were collected by ultracentrifugation. EVs markers and HSCs activation and senescence markers were assessed by Western blot analysis, qPCR and cytochemistry. Reactive oxygen species (ROS) production was assessed by fluorescence assay. RNA profiles of EVs were evaluated by sequencing. We found that EVs from hepatocytes treated with FFAs (FFA‐EVs) inhibit collagen type 1 and α‐smooth muscle actin expression, increase the production of ROS and the expression of senescence markers (IL‐6, IL‐1β, p21 and senescence‐associated β‐galactosidase activity) in early activating HSCs via the AKT–mTOR pathway. Sequencing showed differentially enriched RNA species between the EVs groups. In conclusion, EVs from FFA‐treated hepatocytes inhibit HSC activation by inducing senescence via the AKT–mTOR signaling pathway. Determining the components in EVs from steatotic hepatocytes that induce HSC senescence may lead to the identification of novel targets for intervention in the treatment of MASLD in the future.

cell biology,biochemistry & molecular biology
[Experimental studies on intraluminal administration of oxygenated perfluorochemical (PFC) emulsion to the ischemic gastrointestinal tract].

K. Mizutani

1986-05-01

Abstract:
Novel ordering in the XY spin glass.

Goldbart,Mártin

DOI: https://doi.org/10.1103/PHYSREVB.34.2032

1986-08-01

Abstract:
Hepatic small extracellular vesicles promote microvascular endothelial hyperpermeability during NAFLD via novel-miRNA-7

Rui Zuo,Li-Feng Ye,Yi Huang,Zi-Qing Song,Lei Wang,Hui Zhi,Min-Yi Zhang,Jie-Yi Li,Li Zhu,Wen-Jing Xiao,Hong-Cai Shang,Yang Zhang,Rong-Rong He,Yang Chen

DOI: https://doi.org/10.1186/s12951-021-01137-3

IF: 10.2

2021-11-27

Journal of Nanobiotechnology

Abstract:Abstract Background A recent study has reported that patients with nonalcoholic fatty liver disease (NAFLD) are more susceptible to coronary microvascular dysfunction (CMD), which may predict major adverse cardiac events. However, little is known regarding the causes of CMD during NAFLD. In this study, we aimed to explore the role of hepatic small extracellular vesicles (sEVs) in regulating the endothelial dysfunction of coronary microvessels during NAFLD. Results We established two murine NAFLD models by feeding mice a methionine-choline-deficient (MCD) diet for 4 weeks or a high-fat diet (HFD) for 16 weeks. We found that the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome-dependent endothelial hyperpermeability occurred in coronary microvessels during both MCD diet and HFD-induced NAFLD. The in vivo and in vitro experiments proved that novel-microRNA(miR)-7-abundant hepatic sEVs were responsible for NLRP3 inflammasome-dependent endothelial barrier dysfunction. Mechanistically, novel-miR-7 directly targeted lysosomal associated membrane protein 1 (LAMP1) and promotes lysosomal membrane permeability (LMP), which in turn induced Cathepsin B-dependent NLRP3 inflammasome activation and microvascular endothelial hyperpermeability. Conversely, a specific novel-miR-7 inhibitor markedly improved endothelial barrier integrity. Finally, we proved that steatotic hepatocyte was a significant source of novel-miR-7-contained hepatic sEVs, and steatotic hepatocyte-derived sEVs were able to promote NLRP3 inflammasome-dependent microvascular endothelial hyperpermeability through novel-miR-7. Conclusions Hepatic sEVs contribute to endothelial hyperpermeability in coronary microvessels by delivering novel-miR-7 and targeting the LAMP1/Cathepsin B/NLRP3 inflammasome axis during NAFLD. Our study brings new insights into the liver-to-microvessel cross-talk and may provide a new diagnostic biomarker and treatment target for microvascular complications of NAFLD. Graphical Abstract

biotechnology & applied microbiology,nanoscience & nanotechnology
Cellular communication network factor 1-stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis

Ki-Hyun Kim,Naiyuan Cheng,Lester F Lau

DOI: https://doi.org/10.1002/hep4.2057

Abstract:Following inflammatory injury in the liver, neutrophils quickly infiltrate the injured tissue to defend against microbes and initiate the repair process; these neutrophils are short lived and rapidly undergo apoptosis. Hepatic stellate cells (HSCs) are the principal precursor cells that transdifferentiate into myofibroblast-like cells, which produce a large amount of extracellular matrix that promotes repair but can also lead to fibrosis if the injury becomes chronic. The matricellular protein cellular communication network factor 1 (CCN1) acts as a bridging molecule by binding phosphatidylserine in apoptotic cells and integrin αv β3 in phagocytes, thereby triggering efferocytosis or phagocytic clearance of the apoptotic cells. Here, we show that CCN1 induces liver macrophage efferocytosis of apoptotic neutrophils in carbon tetrachloride (CCl4 )-induced liver injury, leading to the production of activated transforming growth factor (TGF)-β1, which in turn induces HSC transdifferentiation into myofibroblast-like cells that promote fibrosis development. Consequently, knock-in mice expressing a single amino acid substitution in CCN1 rendering it unable to bind αv β3 or induce efferocytosis are impaired in neutrophil clearance, production of activated TGF-β1, and HSC transdifferentiation, resulting in greatly diminished liver fibrosis following exposure to CCl4 . Conclusion: These results reveal the crucial role of CCN1 in stimulating liver macrophage clearance of apoptotic neutrophils, a process that drives HSC transdifferentiation into myofibroblastic cells and underlies fibrogenesis in chronic liver injury.
Spin‐Label EPR on α‐Synuclein Reveals Differences in the Membrane Binding Affinity of the Two Antiparallel Helices

M. Drescher,F. Godschalk,G. Veldhuis,B. V. van Rooijen,V. Subramaniam,M. Huber

DOI: https://doi.org/10.1002/cbic.200800238

IF: 3.2

2008-10-13

ChemBioChem

Abstract:The putative function of the Parkinson's disease‐related protein α‐Synuclein (αS) is thought to involve membrane binding. Therefore, the interaction of αS with membranes composed of zwitterionic (POPC) and anionic (POPG) lipids was investigated through the mobility of spin labels attached to the protein. Differently labelled variants of αS were produced, containing a spin label at positions 9, 18 (both helix 1), 69, 90 (both helix 2), and 140 (C terminus). Protein binding to POPC/POPG vesicles for all but αS140 resulted in two mobility components with correlation times of 0.5 and 3 ns, for POPG mole fractions >0.4. Monitoring these components as a function of the POPG mole fraction revealed that at low negative‐charge densities helix 1 is more tightly bound than helix 2; this indicates a partially bound form of αS. Thus, the interaction of αS with membranes of low charge densities might be initiated at helix 1. The local binding information thus obtained gives a more differentiated picture of the affinity of αS to membranes. These findings contribute to our understanding of the details and structural consequences of αS–membrane interactions.
The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche

Ester Gonzalez‐Sanchez,Javier Vaquero,Daniel Caballero‐Diaz,Jan Grzelak,Noel P Fusté,Esther Bertran,Josep Amengual,Juan Garcia‐Saez,Beatriz Martín‐Mur,Marta Gut,Anna Esteve‐Codina,Ania Alay,Cedric Coulouarn,Silvia Calero‐Perez,Pilar Valdecantos,Angela M Valverde,Aránzazu Sánchez,Blanca Herrera,Isabel Fabregat

DOI: https://doi.org/10.1002/path.6299

2024-06-16

The Journal of Pathology

Abstract:Liver fibrosis is the consequence of chronic liver injury in the presence of an inflammatory component. Although the main executors of this activation are known, the mechanisms that lead to the inflammatory process that mediates the production of pro‐fibrotic factors are not well characterized. Epidermal growth factor receptor (EGFR) signaling in hepatocytes is essential for the regenerative processes of the liver; however, its potential role in regulating the fibrotic niche is not yet clear. Our group generated a mouse model that expresses an inactive truncated form of the EGFR specifically in hepatocytes (ΔEGFR mice). Here, we have analyzed the response of WT and ΔEGFR mice to chronic treatment with carbon tetrachloride (CCl4), which induces a pro‐inflammatory and fibrotic process in the liver. The results indicated that the hallmarks of liver fibrosis were attenuated in CCl4‐treated ΔEGFR mice when compared with CCl4‐treated WT mice, coinciding with a faster resolution of the fibrotic process and ameliorated damage. The absence of EGFR activity in hepatocytes induced changes in the pattern of immune cells in the liver, with a notable increase in the population of M2 macrophages, more related to fibrosis resolution, as well as in the population of lymphocytes related to eradication of the damage. Transcriptome analysis of hepatocytes, and secretome studies of extracellular media from in vitro experiments, allowed us to elucidate the specific molecular mechanisms regulated by EGFR that mediate hepatocyte production of both pro‐fibrotic and pro‐inflammatory mediators; these have consequences for the deposition of extracellular matrix proteins, as well as for the immune microenvironment. Overall, our study uncovered novel mechanistic insights regarding EGFR kinase‐dependent actions in hepatocytes that reveal its key role in chronic liver damage. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

oncology,pathology
Faeces-derived extracellular vesicles participate in the onset of barrier dysfunction leading to liver diseases

Lionel Fizanne,Alexandre Villard,Nadia Benabbou,Sylvain Recoquillon,Raffaella Soleti,Erwan Delage,Mireille Wertheimer,Xavier Vidal-Gómez,Thibauld Oullier,Samuel Chaffron,M Carmen Martínez,Michel Neunlist,Jérôme Boursier,Ramaroson Andriantsitohaina

DOI: https://doi.org/10.1002/jev2.12303

Abstract:The role of extracellular vesicles (EVs) from faeces (fEVs) and small circulating EVs (cEVs) in liver diseases such as non-alcoholic fatty diseases (NAFLD) and non-alcoholic steatohepatitis (NASH) has not been demonstrated. fEVs and cEVs of healthy donors, NAFLD and NASH patients were isolated and characterized. The effects of EVs were evaluated in intestinal, endothelial, Kupffer and stellate cells. Non-muscular myosin light chain kinase (nmMLCK) deficient mice were used in vivo. Bacterial origins of fEVs were analysed by 16s rDNA gene sequencing. fEVs and small cEVs were composed of prokaryotic and eukaryotic origins. Only NASH-fEVs exerted deleterious effects. NASH-fEVs increased intestinal permeability and reduced expression of tight junction proteins that were prevented by nmMLCK inhibition, increased endothelial cell permeability and inflammatory cytokines and chemokines requiring TLR4/lipopolysaccharide pathway. NASH-fEVs and NASH-cEVs activated profibrotic and proinflammatory proteins of hepatic stellate cells. Treatment with NASH-fEVs evoked an increase in intestinal permeability in wild type but not in nmMLCK deficient mice. Bacterial origins of fEVs were different between NAFLD and NASH patients and 16 amplicon sequence variants were differentially abundant. We demonstrate that fEVs actively participate in barrier dysfunctions leading to liver injuries underscoring the role of nmMLCK and lipopolysaccharide carried by fEVs.

Inhibition of enzymatic proteolysis; effect of carbonyl group reagents on the activity of kidney cathepsins.

Extracellular Vesicle-Associated Neutrophil Elastase Activates Hepatic Stellate Cells and Promotes Liver Fibrogenesis via ERK1/2 Pathway

Extracellular vesicles-derived ferritin from lipid-induced hepatocytes regulates activation of hepatic stellate cells

The differential radiated power of a sinusoidal filament of electric current

Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1

Eggshell Membrane Ameliorates Hepatic Fibrogenesis in Human C3A Cells and Rats Through Changes in PPARγ-Endothelin 1 Signaling.

Characterization of highly porous polymeric materials with pore diameters larger than 100 nm by mercury porosimetry and X-ray scattering methods.

Inspiratory flow rates during hard work when breathing through different respirator inhalation and exhalation resistances.

Heparan Sulfate Proteoglycan-Mediated Internalization of Extracellular Vesicles Ameliorates Liver Fibrosis by Targeting Hepatic Stellate Cells

Contribution of Hepatic Steatosis-Intensified Extracellular Vesicle Release to Aggravated Inflammatory Endothelial Injury in Liver-Specific Asah1 Gene Knockout Mice

Threat Description for the PP by Using the Concept of the Assets Protected by TOE

Wharton's Jelly mesenchymal stem cell-derived extracellular vesicles induce liver fibrosis-resolving phenotype in alternatively activated macrophages

Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets

Extracellular vesicles originating from steatotic hepatocytes promote hepatic stellate cell senescence via AKT/mTOR signaling

[Experimental studies on intraluminal administration of oxygenated perfluorochemical (PFC) emulsion to the ischemic gastrointestinal tract].

Novel ordering in the XY spin glass.

Hepatic small extracellular vesicles promote microvascular endothelial hyperpermeability during NAFLD via novel-miRNA-7

Cellular communication network factor 1-stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis

Spin‐Label EPR on α‐Synuclein Reveals Differences in the Membrane Binding Affinity of the Two Antiparallel Helices

The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche

Faeces-derived extracellular vesicles participate in the onset of barrier dysfunction leading to liver diseases